These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5120610)

  • 1. Effect of treatment with two related dimethanesulfonates on the life span and spleen and bone marrow cells of leukemic and nonleukemic mice.
    Vadlamudi S; Padarathsingh M; Waravdekar VS; Goldin A
    Chemotherapy; 1971; 16(2):65-75. PubMed ID: 5120610
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.
    Vadlamudi S; Choudry JN; Waravdekar VS; Kline I; Goldin A
    Cancer Res; 1970 Feb; 30(2):362-9. PubMed ID: 5458970
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL; Uyeki EM
    J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Fernandes DJ; Klubes P
    Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells.
    Fodstad O; Pihl A
    Int J Cancer; 1978 Nov; 22(5):558-63. PubMed ID: 721316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemotherapy screening with experimental tumors which metastasize to lymph nodes.
    Tsukagoshi S; Sakurai Y
    Cancer Chemother Rep; 1970 Oct; 54(5):311-8. PubMed ID: 5514619
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the sequence of administration of cytoxan and methotrexate on the life-span of L1210 leukemic mice.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1972 Feb; 32(2):200-7. PubMed ID: 5058180
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
    Skórski T; Kawalec M
    Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (L1210) mice.
    Vadlamudi S; Padarathsingh M; Bonmassar E; Goldin A
    Int J Cancer; 1971 Jan; 7(1):160-6. PubMed ID: 4925903
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tehe effect of certain mono-functional methanesulphonoxy-alkanes on haemopoietic colony forming units in the rat.
    Dunn CD; Elson LA
    Rev Eur Etud Clin Biol; 1970; 15(7):771-4. PubMed ID: 4921487
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of drug combination of antitumor activity and myelotoxicity.
    Fujimoto S; Inouye T; Tsukagoshi S
    Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antitumor agents on the hematology and transplantability of leukemia L-1210.
    Eckhardt S; Humphreys SR; Goldin A
    Antimicrob Agents Chemother (Bethesda); 1965; 5():503-8. PubMed ID: 5883466
    [No Abstract]   [Full Text] [Related]  

  • 16. Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agents.
    Paprocka M; Wiedlocha A; Radzikowski C
    In Vivo; 1990; 4(3):209-13. PubMed ID: 2133264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of classic immunosuppressants on spleen colony formation in mice. 3. Concentration of colony forming units in bone marrow and spleens of cyclophosphamide-treated mice.
    Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1979; 27(4):517-21. PubMed ID: 518257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
    Buurman WA; van Bruggen I
    Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered sensitivity of hematopoietic stem cells to 5-fluorouracil (NSC-19893) following endotoxin (NSC-189681), cyclophosphamide (NSC-26271), or irradiation.
    Eaves AC; Bruce WR
    Cancer Chemother Rep; 1974; 58(6):813-20. PubMed ID: 4447924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.